L Albiges

Novel pembrolizumab-based treatments as eerstelijns therapy in gevorderd clear-cell renal cell carcinoma: substudy 03...

Annals of oncology : official journal of the European Society for Medical Oncology · 2026-02

Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell car...

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-12

Prospective gerandomiseerde phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal ce...

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-07

Avelumab + axitinib versus sunitinib as eerstelijns treatment for patiënten met gevorderd renal cell carcinoma: final...

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-04

Subcutaan versus intraveneus nivolumab bij niercelcarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2025-01

Niercelcarcinoom: ESMO 2024 richtlijn

Annals of oncology : official journal of the European Society for Medical Oncology · 2024-08

ESMO-richtlijn voor immunotherapie bij vroeg en gevorderd RCC: 2021 update

Annals of oncology : official journal of the European Society for Medical Oncology · 2021-12

JAVELIN Renal 101: geactualiseerde werkzaamheid van avelumab-axitinib versus sunitinib bij mRCC

Annals of oncology : official journal of the European Society for Medical Oncology · 2020-08

Vinflunine-gemcitabine versus vinflunine-carboplatine als eerstelijns bij cisplatine-ineligibel urotheelcelcarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2016-03

Publicaties op Oncologisch.com